Generic drug ETF ailing despite political focus on high drug prices
NEW YORK, March 3 (Reuters) - Calls in the U.S. presidential campaign to cut pharmaceutical prices are not helping to revive a barely two-month-old exchange-traded fund that invests in shares of...
Read more »